Announcements Trials
Browse Landscape

Phase

Phase 3 3

Status

Completed 3Withdrawn 1

Sponsor Class

NETWORK 4INDUSTRY 2OTHER 1

Study Type

Interventional 3Observational 1

Sponsor

Cancer Type

Breast 3Genitourinary 1

Conditions

Breast Neoplasms 3Prostatic Neoplasms 1Pain 1

Interventions

Radiotherapy 302Cisplatin 266Cyclophosphamide 230Doxorubicin 177Paclitaxel 171Vincristine 162Carboplatin 153Filgrastim 140Etoposide 139Gemcitabine 118Docetaxel 114Fluorouracil 113Methotrexate 106Dexamethasone 106Cytarabine 106Prednisone 92Leucovorin 90Gene Expression Profiling 82Granulocyte Colony-Stimulating Factor 75Specimen Handling 71Magnetic Resonance Spectroscopy 64Irinotecan 59Capecitabine 59Radiation 54Polymerase Chain Reaction 51Ifosfamide 51Rituximab 49Immunohistochemistry 49Daunorubicin 49Oxaliplatin 48

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
NETWORK × Clodronic Acid × Clear all
NCT00127205 2021-07-02

S0307 Phase III Trial of Bisphosphonates as Adjuvant Therapy for Primary Breast Cancer.

SWOG Cancer Research Network

Phase 3 Completed
6,097 enrolled 20 charts
Breast

Breast Neoplasms

NCT00003232 2020-04-03

Combination Chemotherapy in Treating Pain in Hormone Refractory Metastatic Prostate Cancer

Canadian Cancer Trials Group

Phase 3 Completed
227 enrolled
Genitourinary

Pain, Prostatic Neoplasms

NCT00009945 2017-12-13

Clodronate With or Without Chemotherapy and/or Hormonal Therapy in Treating Women With Stage I or Stage II Breast Cancer

NSABP Foundation Inc

Phase 3 Completed
3,323 enrolled 12 charts
Breast

Breast Neoplasms

NCT00873808 2013-04-10

S0307A, Long-Term Bone Quality in Women With Breast Cancer Enrolled on Clinical Trial SWOG-S0307

SWOG Cancer Research Network

Withdrawn
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡